Research Article Volume 2 Issue 3
Department of Forensic Medicine and Clinical Toxicology, Ain Shams University, Egypt
Correspondence: Mohy K El Masry, Department of Forensic Medicine and Clinical Toxicology, Ain Shams University Hospitals, Abbassiah, Cairo, Egypt, Tel 2022 7764 801
Received: August 27, 2016 | Published: December 28, 2016
Citation: Mohy EMK, Mohamed AA, Husam E. Urine carbamate determination compared with plasma pseudocholinesterase for diagnosis of insecticides poisoning. MOJ Toxicol. 2016;2(3):76–80. DOI: 10.15406/mojt.2016.02.00040
Introduction: Diagnosis of carbamate poisoning is frequently missed especially when patients present after the recovery of pseudocholinesterase inhibition. Confusion is due to the similarity of the clinical picture with that of food poisoning and other infectious syndromes.
Patients and methods: Patients (n=40) admitted within 4 hours of carbamate intoxication were included in the study. They were graded according to Poison severity score PSS. Normal volunteers (n=10) were included and served as negative control group. Normal subjects and all patients were tested for plasma pseudocholinesterase (PsChE) within 4 hours and 18 hours from carbamates exposure. Urine carbamate concentration was determined on the 18th hour and 2 days after exposure. Different PSS groups and normal volunteers were compared for their plasma PsChE and urine carbamate levels using student t test and correlation coefficient Method used for PsChE determination is the kinetic assay method. Urine carbamate concentrations were determined by spectrophotometry using modification of the method of Tamrakar. Carbamate determination method was tested for linearity, precision, recovery and limit of detection of the carbamates
Results: PsChE was significantly lower in PSS II compared to PSS I. No significant difference in PsChE was noticed between both patient’s groups and normal volunteers on the 18th hour from carbamate exposure. Urine carbamate concentration was significantly higher in PSS II compared to PSS I on the 18th hour and 2 days after exposure. No correlation was detected between the maximum urine carbamate concentration and plasma pseudocholinesterase. The method specificity increased after modification from 76.9 to 91%. Recovery ranged between 95 and 98%. Limit of detection is 0.1µg/ml and limit of quantification is 0.2µg/ml. The technique is highly reproducible with inter-day precision RSD less than 8%.
Conclusion: A better evaluation and diagnosis of carbamate poisoning patients with delayed presentation can be achieved using urine carbamate determination rather than plasma pseudocholinesterase which is often normalized at the time of presentation
Keywords: pseudocholinesterase, carbamate poisoning, urine carbamate concentration
Carbamate insecticides act similarly to the organophosphates in that they inhibit acetyl cholinesterase enzyme (AChE) at nerve synapses and neuromuscular junctions. This inhibition is reversible with spontaneous hydrolysis occurring usually within several hours1 thus, the inhibition of blood AChE is frequently not evident at the laboratory.2 There are two main pharmacokinetic characteristics that distinguish carbamates from organic phosphorus compounds. First, carbamate insecticides do not easily cross into the central nervous system.3 CNS effects of carbamates are thus limited. Second, the carbamate-cholinesterase bond does not “age” as in organic phosphorus compound poisoning. In Egypt, poisoning by carbamates is increasing in frequency. Diagnosis is frequently missed when the case is admitted after considerable delay with an almost normalized pseudo-cholinesterase and a normal true AChE on presentation. In 2011, the poison control center of Ain Shams University received and treated 259 carbamate poisoning cases.4 In other hospitals and health care centers, records underestimate outbreaks of carbamates toxic exposure attributing them to bacterial food poisoning. Most of these outbreaks are due to premature crop harvesting. According to agricultural pesticides committee in Egypt the recommended preharvest interval for carbamate application ranges between 7 and 90 days. Rejection of many of the Egyptian agricultural goods by the European Union is commonly due to non-compliant exportation samples containing above allowed pesticides carbamates residues.5 Carbofuran, a pesticide, is a major metabolite of carbosulfan, commonly used nematicide in Egypt. Spectrophotometric determination of different carbamates in food residues and biological samples have been described using various coupling reagents6 as diazotized trimethylaniline of 0.2-2 µg/ml7 or 2, 6-dibromo-4-methylaniline, 2,6-dibromo-4-nitroaniline or 2,4,6-tribromoaniline8 to form stable diazo dye with a satisfactory limit of detection. Other diazotized p-aminoacetophenone (DPAAP) was suggested under alkaline condition. The method was sensitive, posed no interference and azo dye was more stable than other various coupling reagents. Compared with chromatographic methods, the spectrophotometric determination of N-methyl carbamates was a simple, sensitive, much less expensive and sensitive to parent compounds as well as metabolites.9
Subjects
Samples and laboratory tests
Quantitative estimation of serum pseudocholinesterase was determined using the colorimetric kinetic method of Young et al.10 Chemicals were provided by Diamonds Chemicals Co. The assay depends on the action of pseudocholinesterase on butyrilthiocholine substrate in phosphate buffer resulting in thiocholine. In presence of 5, 5’-dithiobis-(2-nitrobenzoic acid), thiocholine produces 5-mercapto-2-nitrobenzoic acid and mixed disulfide. Delta absorbance at 450 nm is calculated every 30 seconds at 37° C to determine pseudocholinesterase activity.
Quantitative estimation of urine carbamates was determined using a modification of Tamrakar et al.9 in the following groups of samples
Reagents
Extraction procedure of carbamates from urine, fruits and vegetable samples
A double extraction is performed with 10 ml chloroform with equal volume of urine. The mixture is vigorously shaken for 5 minutes and vortex. The sample is then centrifuged and the organic layers of the extraction separated and evaporated to dryness under a stream of air. The residue is reconstituted in 100 µl 10% glacial acetic acid then diluted by 900 µl distilled water to reach 1% acetic acid concentration. The extract is then diluted with 9 ml 1% acetic acid to reach 10 ml.
Procedure of carbamate quantitative determination
The method is based on the coupling of a carbamate pesticide with diazotized p-aminoacetophenone (DPAAP) under alkaline condition. The orange dye formed is measured at 460 nm. The procedure is based on a modification of the test described by Tamrakar et al.9 To 1ml blank, urine sample or carbamate standards containing various concentrations (2-25 µg/ml) of carbosulfan in 1% glacial acetic acid, 2 ml of freshly prepared DPAAP are added and left for 5 minutes. To the above mixture, 0.5 ml of 2 Mol/L NaOH is added. Vortex and rapid shaking for 20 seconds aimed to avoid the formation of a precipitate. The color is read at 450 nm against blank after 5 minutes. The color is stable for one hour. Absorbance is plotted against concentrations on a daily performed standard curve.
Calculation
A standard calibration curve is constructed. Intra-day and inter-day precision calculated from the standard samples. Recovery of the extracted carbamate from spiked standard samples is calculated. To determine the limit of detection of the equipment for the method assay of carbamates, a negative control sample was run under the experimental conditions to obtain the absorbance baseline noise. A detectable compound should produce a signal that is at least three times the baseline noise [that is, signal-to-noise (S/N) ratio = 3].12
Patients were graded on admission according to Poison severity score PSS11 to grade I (19 cases) or grade II (21 cases). All cases of grade I PSS, presented with mild cholinergic signs, sweating, vomiting, diarrhea, irritability and mild dyspnea. In addition, patients with grade II PSS manifested prolonged vomiting and diarrhea, pronounced cholinergic signs, moderate to severe dyspnea, bronchospasm, hypoxemia (4 cases) requiring oxygen supplementation, muscle fasciculations, disturbed conscious level (in 9 cases) and isolated seizure (in 2 cases). Manifestations and signs of toxicity were regressing and disappeared totally after an average of 1.6 days in grade I and 2.2 days in grade II PSS patients. Plasma pseudocholinesterase was significantly lower in grade II than in grade I PSS patients (p < 0.05) on admission, however no significant difference was observed between the two groups 18-24 hours after admission (Table 1). No significant difference between the negative control group and the carbamate intoxicated patients 18-24 hours after admission despite the significant residual manifested symptomatology (Table 2). In both Grade I and II PSS patients, the plasma pseudocholinesterase significantly rose after 18- 24 hours from ingestion (p <0.00001) (Table 1) Urine carbamate levels were significantly higher in Grade II (9.86 µg/ml) compared to Grade I (3.77 µg/ml) PSS patients (p < 0.01). Levels at 18 - 24 hours in urine confirmed carbamate exposure and confirmed the degree of clinical severity (Table 3). At 48 hours after exposure the urine carbamate levels were still significantly different among the two groups (p<0.05). In grade I PSS patients, the urine carbamate levels significantly decreased 48 hours (1.4 µg/ml) compared to 18-24 hours after ingestion (3.77µg/ml) (p <0.05). Similarly in Grade II PSS patients, the urine carbamate levels significantly decreased 48 hours (4.64 µg/ml) compared to 18-24 hours after ingestion (9.86 µg/ml) (p <0.01). Methyl carbamates urinary excretion decreased by 50.9% (grade I PSS patients) and 63.2% (grade II PSS patients) at 48 hours compared to 18-24 hours; however the percentage reduction was not different in both groups (Table 4). No correlation was evident between clinical findings of carbamate-intoxicated patients and plasma pseudocholinesterase 18-24 hours after exposure. No significant correlation (r²=0.188) existed between the lowest plasma pseudocholinesterase (less than 4 hours) and urinary carbamates concentration tested 18-24 hours from exposure (Table 5). Table 1 Statistical comparison of plasma pseudocholinesterase PsCHE in different poison severity score (PSS), on admission and 12-24 hours after ingestion using t-test
Grade I PSS |
Grade II PSS |
|||
N=19 |
N=21 |
|||
Ps CHE (U/L) Within the first 4 h of exposure (admission) |
Range |
685 - 3120 |
644 - 2116 |
t= 1.7377- P= 0.0456. Result is significant at p < 0.05. |
Mean |
1573 |
1222.5 |
||
Ps CHE (U/L) 18 to 24 hours after exposure |
Range |
4340 - 7000 |
3700 - 7080 |
t=1.0496 P=0.1504 Not significant at p < 0.05. |
Mean |
5453 |
5117 |
||
t= 14.2044 P= <0.00001. Significant at p < 0.05. |
t=14.4138 P-= < 0.00001. Significant at p < 0.05. |
|||
P-= < 0.00001. Significant at p < 0.05. |
Table 1 Statistical comparison of plasma pseudocholinesterase Ps CHE in different poison severity score (PSS), on admission and 12-24 hours after ingestion using t-test
Negative Control n=10 |
Patient’s P ChE* n=40 |
t-test |
|
Range |
4900 - 7400 |
3700 - 7080 |
t=1.5604 P = 0.103 Non-significant |
Mean ± SD |
5855.5 ± 849 |
5315.4 ± 1003 |
Table 2 Statistical comparison of negative control and patient’s plasma pseudocholinesterase (IU/L) 18-24 hours after ingestion using t-test
*plasma pseudocholinesterase 18 – 24 hours post-intoxication
Grade I Poisoning Severity Score |
Grade II Poisoning Severity Score |
|||
Urine Carbamate (µg/ml)18-24 hours |
Number |
N=19 |
N=21 |
t= 4.6 - P=0.000022 Significant at P <0.01 |
Range |
0.21 - 10 |
4.2 – 22.25 |
||
Mean |
3.77 |
9.86 |
||
Urine Carbamate (µg/ml) 48 hours |
Number |
N=5 |
N=15 |
t = 2.06 – P= 0.0268 Significant at P <0.05 |
Range |
0.2 – 3.3 |
1.1 – 11.8 |
||
Mean |
1.4 |
4.64 |
||
t=1.856 – P=0.0383 Significant at P<0.05 |
t=3.495-P=0.00069 Significant at P<0.01 |
Table 3 Statistical comparison of urine carbamate in different poison severity score, 18 to 24 hours and 48 hours following exposure using t-test
Grade I PSS (n=5) |
Grade II PSS (n=15) |
|
18-24 hours Mean conc (µg/ml) |
3.77 |
9.86 |
48 hours Mean conc (µg/ml) |
1.4 |
4.64 |
Range of concentration reduction (%) |
34 – 76.4% |
34.5 – 77.6% |
Mean of concentration reduction (%) |
50.90% |
63.20% |
t= 1.673 - P value 0.056 - Not significant |
Table 4 Statistical comparison of percentage urinary carbamate concentrations reduction, 18-24 hours and 48 hours following exposure in different poison severity score using t-test
Mean |
Range |
Correlation Coefficient |
|
Plasma Pseudocholinesterase in IU/L (within the first 4 hours) |
1301.8 |
644 - 7080 |
r² = -0.188. No significant correlation |
Carbamate urinary excretion in µg/ml on the 18th hour |
6.97 |
0.21 – 22.25 |
Table 5 Correlation between the maximum urine carbamate concentration and plasma pseudocholinesterase
Evaluation of the modified technique
The linearity of the standard calibration curve with concentrations from 1 to 25 µg/ml is good (r² =0.989). Quantification limit is 0.2µg/ml. The limit of detection (0.1µg/ml) is calculated by an absorbance equivalent to three times that of the negative sample. The technique is highly reproducible with inter-day precision RSD less than 8%. Specificity of the test of 76.9% is increased to 91% with some modifications of Tamrakar et al.9 Sensitivity of the test decreases when the solutions are not freshly prepared. Diazotization step is improved when PAAP is kept with freshly prepared 0.2% sodium nitrite in ice bath for at least 20 minutes. Improper extraction occurs with dilute acetic acid. After extraction with chloroform and evaporation the residue is better taken in 10% acetic acid after which it is diluted to 1% by distilled water. Precipitation that might develop after addition of NaOH is avoided by limiting the volume of 2 molar NaOH to 0.5 ml and vigorous shaking after addition. Recovery of carbamate using this extraction method ranged between 95 and 98% using 5 and 10 µg/ml standards.
Patients affected with vomiting and diarrhea suggesting mild carbamate poisoning or food borne illness frequently presents late escaping the significant decrease of plasma pseudocholinesterase which is maximally inhibited 45 minutes after oral ingestion.13 Clinical differentiation is sometimes difficult. In this study it is evident that plasma pseudocholinesterase is normal 18 hours after ingestion of carbamates regardless of the severity of carbamate poisoning. Confirmation of poisoning was achieved by urine carbamate levels 18 hours after ingestion when laboratory confirmation was no more possible by plasma pseudocholinesterase. Although plasma pseudocholinesterase in PSS II patients is significantly lower than in milder clinical cases (PSS I), yet no significant difference was evident in plasma pseudocholinesterase between negative control and different severity score patients after 18 hours from exposure. According to EPA,14 unless a substantial amount of N-methyl carbamate has been absorbed and a blood sample is taken within an hour or two, it is unlikely that blood cholinesterase activities will be found depressed since enzyme reactivation occurs in vitro as well as in vivo. It is a commonly recommended, in clinical practice, to start atropine treatment and not to wait for test result. Presence of atropine refractoriness is a clinical confirmation of severe carbamates or organophosphorus toxicity. Problems in laboratory confirmation of diagnosis and assessment of severity score after the first few hours of poisoning evidently appear easier with identification and quantification of N-methyl carbamates metabolites in urine. Evidently urinary carbamates levels were significantly higher in PSS II than in milder PSS I patients. This significant difference still existed after the elapse of 48 hours from carbamates exposure elaborating the significance of the urinary carbamates test in such patients. Clinical diagnosis of carbamates poisoning is not always rapid and condition is not always benign. Differentiating carbamates from organophosphates based on clinical presentation is often difficult because of the similarity of symptoms, yet urgent treatment decisions must often precede analytical or historical confirmation. Atropine is the primary drug used to treat symptomatic cases involving both organophosphate and carbamate insecticides.15 Methomyl, a highly toxic N-methyl carbamate, has been reported to cause a fulminant hepatic failure and death. Fatal outcome often results following respiratory depression and pulmonary edema16 Urinary elimination of carbamates has been scarcely studied in man. In rats, carbamate insecticides are well absorbed across skin and mucous membranes, and by inhalation and ingestion. Peak serum levels of some compounds are measured 30-40 minutes following ingestion.1 It was found that 32-37% of a dose is excreted in 20 hours17 while 75-80 % of 1-naphthyl-N- methyl carbamates (carbaryl) are eliminated in the expired air and urine in 48 hours of larvae.17 Carbofuran is eliminated by conjugation in the urine (14-15%) or in expired air (45%) of rats.18 Most carbamates undergo hydrolysis, hydroxylation, and conjugation in the liver and intestinal wall, with 90% excreted in the urine within 3 days.19 In intoxicated patients the symptoms start at 20-30 minutes following ingestion. This onset corresponds to the peak described by Flomenbaum et al.1 Symptoms also correlated with peak Carbofuran concentration at 30 minute following oral ingestion.13 Carbamates and metabolites urinary concentrations were maximal at 18-24 hours. It was diminished 36 to 79% at 48 hours. Although urine carbamate levels were significantly higher in grade II compared to grade I PSS patients, yet levels did not correlate with plasma cholinesterase maximum inhibition within 4 hours from ingestion. This might be explained by the variability of carbamate elimination. Toxicokinetic of carbamates in humans is apparently similar to that of rats; however more controlled studies are warranted for the description of carbamates toxicokinetic in humans.
A better diagnosis and severity assessment of carbamate poisoning patients with a delayed presentation can be achieved using urine carbamate determination rather than plasma pseudocholinesterase which is often normalized at the time of presentation.
None.
The author declares no conflict of interest.
©2016 Mohy, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.